Gut Microbiome

DYSBIOSIS OF GUT MICROBIOTA IN PATIENTS HOSPITALIZED FOR THE TREATMENT OF ALCOHOL USE DISORDER.

TL;DR

Patients with Alcohol Use Disorder exhibit changes in intestinal microbiota composition, potentially associated with low-grade inflammation and functional alterations that contribute to the development of diseases, and the composition of intestinal microbiota and its bioactive metabolites may serve as novel therapeutic targets for the treatment of AUD.

Key Findings

Gut microbiota alpha diversity differed among the control, AUD-T1 (admission) and AUD-T2 (discharge) groups.

  • ACE index differed among groups (P<0.004).
  • Shannon index differed among groups (P<0.017).
  • Observed taxa differed among groups (P=0.002).
  • The study included 50 control participants and 47 patients admitted for AUD treatment.

The inflammatory marker myeloperoxidase was significantly higher in AUD patients at admission than in controls, while E-selectin showed the opposite pattern.

  • Myeloperoxidase concentration was significantly higher in the AUD-T1 group compared with controls (P<0.001).
  • E-selectin showed the opposite pattern (P<0.001), i.e., it was lower in AUD-T1 than in controls.
  • Markers were measured at hospital admission for the AUD-T1 group and in the control group.

Several bacterial genera were more abundant in controls than in AUD patients at admission.

  • The LEfSe algorithm identified higher abundance of Faecalibacterium, Bacteroides, Agathobacter, and unclassified Ruminococcaceae in the control group compared with AUD-T1.
  • Gut microbiota composition was evaluated at admission in AUD-T1 and controls.

No differences in bacterial genus abundance were found between the AUD-T1 (admission) and AUD-T2 (discharge) groups.

  • AUD-T2 was assessed at discharge from hospital treatment.
  • The microbiota alterations observed at admission were therefore not shown to differ after the hospital treatment period.

The study was a prospective cohort of patients hospitalized for AUD treatment compared with a control group.

  • The mean age in the AUD-T1 group was 49.3 years, and all were male.
  • Demographic, clinical, laboratory, and inflammatory marker data were assessed at admission for AUD-T1 and in controls.
  • The main objective was to assess the chronic effect of alcohol on the composition and diversity of intestinal microbiota.

The authors conclude that AUD is associated with dysbiosis potentially linked to low-grade inflammation, and that microbiota and its metabolites may be therapeutic targets.

  • Changes in microbiota composition were described as potentially associated with low-grade inflammation and functional alterations that contribute to disease development.
  • Intestinal microbiota and its bioactive metabolites are proposed as novel therapeutic targets for AUD.

What This Means

This study compared the gut bacteria of 47 men hospitalized for alcohol use disorder with those of 50 control participants. Patients were sampled when they were admitted and again at hospital discharge. At admission, patients had different levels of gut bacterial diversity than controls, and had lower amounts of several bacteria often considered beneficial, including Faecalibacterium, Bacteroides, Agathobacter and a group of Ruminococcaceae. Patients also showed signs of inflammation: myeloperoxidase, an inflammatory marker, was higher than in controls, while E-selectin was lower. The authors suggest that these gut changes may be linked to low-grade inflammation and to health problems associated with heavy drinking. However, the bacterial makeup did not significantly differ between admission and discharge, so the hospital stay did not clearly restore the gut bacteria within that time. This research suggests that gut bacteria and the substances they produce could one day be explored as targets for treating alcohol use disorder. The study was observational and involved only men, so it cannot show that alcohol directly caused these changes or that altering gut bacteria would improve treatment outcomes.

Have a question about this study?

Citation

Thoen R, Longo L, Basso B, Rampelotto P, Sordi A, Kessler F, et al.. (2026). DYSBIOSIS OF GUT MICROBIOTA IN PATIENTS HOSPITALIZED FOR THE TREATMENT OF ALCOHOL USE DISORDER.. Arquivos de gastroenterologia. https://doi.org/10.1590/S0004-2803.24612025-144